Company Profile
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Fukangren now has 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base, forming an end-to-end CDMO service system that can provide customers with drug R&D and production.
The development of high-end formulations is a major advantage of Fukangren. Among them, multiple platform projects such as sustained and controlled release formulations, oral membranes, inhalation solutions/aerosols/powder mists, drug-loaded milk, and parenteral nutrition multi-chamber bags are all The customer has realized industrialization, and on this basis has carried out the research and development of a number of innovative preparations.
The development of highly difficult APIs is another major advantage of Fukangren. It has rich technical reserves in asymmetric synthesis, chiral resolution, parallel synthesis, special reactions, multi-step synthesis, and crystal formation research.
There are more than 500 employees in Fukangren, and more than 60% of them have a master's degree or above.
Pharmaceutical R&D Center
Clinical R&D Center
API production base
API production base
Corporate Promotion Video
